BioSyent

For the sixth consecutive year in 2018, BioSyent was named as one of Canada’s fastest growing companies in the GROWTH 500 rankings with a 5 year revenue growth rate of 313%.
BioSyent is a Canadian specialty pharmaceutical company focused on sourcing, acquiring or in-licensing and further developing innovative pharmaceutical and other healthcare products that improve the lives of patients and support their healthcare providers. BioSyent’s strategy is focused on generating long-term growth through portfolio diversification while maintaining profitability.